Abstract:The aim of our minireview is to provide a brief overview of the diagnosis, clinical aspects, treatment options, management, and current literature available regarding herpes simplex keratitis (HSK). This type of corneal viral infection is caused by the herpes simplex virus (HSV), which can affect several tissues, including the cornea. One significant aspect of HSK is its potential to cause recurrent episodes of inflammation and damage to the cornea. After the initial infection, the HSV can establish a latent infection in the trigeminal ganglion, a nerve cluster near the eye. The virus may remain dormant for extended periods. Periodic reactivation of the virus can occur, leading to recurrent episodes of HSK. Factors triggering reactivation include stress, illness, immunosuppression, or trauma. Recurrent episodes can manifest in different clinical patterns, ranging from mild epithelial involvement to more severe stromal or endothelial disease. The severity and frequency of recurrences vary among individuals. Severe cases of HSK, especially those involving the stroma and leading to scarring, can result in vision impairment or even blindness in extreme cases. The cornea's clarity is crucial for good vision, and scarring can compromise this, potentially leading to visual impairment. The management of HSK involves not only treating acute episodes but also implementing long-term strategies to prevent recurrences and attempt repairs of corneal nerve endings via neurotization. Antiviral medications, such as oral Acyclovir or topical Ganciclovir, may be prescribed for prophylaxis. The immune response to the virus can contribute to corneal damage. Inflammation, caused by the body's attempt to control the infection, may inadvertently harm the corneal tissues. Clinicians should be informed about triggers and advised on measures to minimize the risk of reactivation. In summary, the recurrent nature of HSK underscores the importance of both acute and long-term management strategies to preserve corneal health and maintain optimal visual function.

Emerging drugs for the treatment of herpetic keratitis

Common and New Acyclovir Resistant Herpes Simplex Virus-1 Mutants Causing Bilateral Recurrent Herpetic Keratitis in an Immunocompetent Patient

Herpes simplex keratitis: A brief clinical overview

The immunobiology of corneal HSV-1 infection and herpetic stromal keratitis

A Systematic Review On Advances In Diagnostics For Herpes Simplex Keratitis

Current formulation strategies to design novel carriers for targeted drug delivery and management of Infectious keratitis: A comprehensive review on the present state of the art

Clinical translation of recommendations from randomized trials for management of herpes simplex virus keratitis

Recurrent herpetic keratitis despite antiviral prophylaxis: A virological and pharmacological study

Herpes and zoster keratitis

Clinical management of herpes simplex virus infections: past, present, and future

Outcomes of Corneal Transplantation for Herpetic Keratitis: A Narrative Review

Role of Innate Interferon Responses at the Ocular Surface in Herpes Simplex Virus-1-Induced Herpetic Stromal Keratitis

Herpes simplex viral keratitis - A mixed bag of challenging case scenarios

Infectious keratitis: A review

Therapeutic effects and related mechanisms of nerve growth factor on herpes simplex virus keratitis

Harmol used for the treatment of herpes simplex virus induced keratitis

Herpes simplex virus keratitis: electronic medical records driven big data analytics report from a tertiary eye institute of South India

Viral Keratitis, Surgical Intervention in Viral Keratitis, Challenges in Diagnosis and Treatment of Viral Keratitis, HSV, HZV

In Vivo CRISPR Gene Editing in Patients with Herpetic Stromal Keratitis.

Current Antivirals and Novel Botanical Molecules Interfering With Herpes Simplex Virus Infection

A Supramolecular Gel with Unique Rheological Properties for Treating Corneal Virus Infection